Your Partner for Growth, Hybridan

Hybridan

Your Partner for Growth

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Equity Bottom-Up

<ul>
<li>The exploration and development company announced that it has raised gross proceeds of £375,192 via an allotment to Kashif Afzal, a Director of the Company, of 31,266,000 new ordinary shares at an issue price of £0.012 per share, representing a premium of approximately 50% to the closing mid-market price at 8 Oct 2025.</li>
<li>The purchaser will receive one warrant for each New Ordinary Share exercisable at £0.02, where they are exercisable for a period of five years from the date of issue.</li>
<li>The company also sold 443k shares in Sterling Metals Corp for approximately a gross consideration of CAD980k. The Company will retain 400,000 shares in Sterling Metals.</li>
</ul>


The exploration and development company announced that it has raised gross proceeds of £375,192 via an allotment to Kashif Afzal, a Director of the Company, of 31,266,000 new ordinary shares at an issue price of £0.012 per share, representing a premium of approximately 50% to the closing mid-market price at 8 Oct 2025.
The purchaser will receive one warrant for each New Ordinary Share exercisable at £0.02, where they are exercisable for a period of five years from the date of issue.
The company also sold 443k shares in Sterling Metals Corp for approximately a gross consideration of CAD980k. The Company will retain 400,000 shares in Sterling Metals.


<ul>
<li>The medical technology group focused on the durable healing of wounds and the prevention of amputations, today announces that topical oxygen therapy is included in the National Institute for Health and Care Excellence updated Diabetic Foot Problems: Prevention and Management guideline, and the Company's Topical Wound Oxygen therapy is now active on the Advanced Wound Care framework, awarded by NHS Supply Chain.</li>
<li>The updated NICE guidelines include topical oxygen therapy as an adjunct to standard care for diabetic foot ulcers that are not responding to treatment, reflecting increasing recognition from national health authorities of the clinical value and potential of TWO2 therapy to improve outcomes in difficult-to-heal wounds.</li>
</ul>


The medical technology group focused on the durable healing of wounds and the prevention of amputations, today announces that topical oxygen therapy is included in the National Institute for Health and Care Excellence updated Diabetic Foot Problems: Prevention and Management guideline, and the Company's Topical Wound Oxygen therapy is now active on the Advanced Wound Care framework, awarded by NHS Supply Chain.
The updated NICE guidelines include topical oxygen therapy as an adjunct to standard care for diabetic foot ulcers that are not responding to treatment, reflecting increasing recognition from national health authorities of the clinical value and potential of TWO2 therapy to improve outcomes in difficult-to-heal wounds.


Videndum Plc - Hybridan Small Cap Feast: 03/09/2025

United Kingdom

Jangada Mines PLC operates as a holding company. The Company, through its subsidiaries, mines rhodium, nickel, copper, vanadium-titanium, and iron ores. Jangada Mines explores resources in the United Kingdom and Brazil.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Jangada Mines PLC (JAN LN)

Hybridan Small Cap Feast: 09/10/2025

The purchaser will receive one warrant for each New Ordinary Share exercisable at £0.02, where they are exercisable for a period of five years from...

Hybridan

Videndum Plc - Hybridan Small Cap Feast: 03/09/2025

The updated NICE guidelines include topical oxygen therapy as an adjunct to standard care for diabetic foot ulcers that are not responding to...

Hybridan

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)